Back to search
FDAFDA · Food and drugs·Recall number D-0138-2017

FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit , 5 oz., Rx only, Manufactured for CutisPharma Wilmington, MA, NDC# 65628-070-05

Published November 23, 2016 · Recall initiated: October 20, 2016

Summary

FDA records drug Class III recall D-0138-2017, published November 23, 2016 and initiated October 20, 2016. Recalling firm: CutisPharma, Inc.; Status: Terminated; Reported quantity: 8,748 kits; Lot: Lot #: E1414, Exp. 08/2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
CutisPharma, Inc.
Distributor
Nationwide
Lot
Lot #: E1414, Exp. 08/2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit , 5 oz., Rx only, Manufactured for CutisPharma Wilmington, MA, NDC# 65628-070-05 recalled?

Yes. FDA published recall D-0138-2017 on November 23, 2016. Reported hazard: Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL

What should I do if I have this product?

Voluntary: Firm initiated · Letter